期刊文献+

双重抗血小板治疗在预防进展性缺血性脑卒中的作用 被引量:15

下载PDF
导出
摘要 脑梗死是神经内科的高发疾病,在急性期进展的发生率约20%~40%,进展性缺血性脑卒中预后不良。目前国内外对进展性脑卒中研究较多,但尚缺少双重抗血小板治疗与脑梗死进展发生的相关性研究,而且对双重抗血小板治疗的风险及获益尚无定论。本研究旨在探讨双重抗血小板治疗对急性脑梗死患者进展性脑卒中发生的影响。
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2012年第4期362-363,共2页 Journal of Apoplexy and Nervous Diseases
  • 相关文献

参考文献9

  • 1Davalos A,Toni D,Iweins F,et al.Neurological deterioration in acuteischemic stroke:potential predictors and associated factors in the Eu-ropean cooperative acute study(ECASS)[J].Stroke,1999,30:2631-2636.
  • 2王新国.各类脑血管病诊断要点及脑卒中患者临床神经功能缺损程度评分标准.中华神经科杂志,1996,33(6):374-381.
  • 3Han SW,Kim SH,Lee JY,et al.A new subtype classification of ische-mic stroke based on treatment and etiologic mechanism[J].Eur Neu-rol,2007,57:96-102.
  • 4Ois A,Martinez-Rodriguez JE,Munteris E,et al.Steno-occlusive ar-terial disease and early neurological deterioration in acute ischemicstroke[J].Cerebrovasc Dis,2008,25(1~2):151-156.
  • 5李敏,董万利.进展性卒中危险因素的临床分析[J].中国脑血管病杂志,2010,7(4):187-190. 被引量:14
  • 6耿学川,盖红,杜继臣.早期进展性卒中诊断与病因机制[J].中国实用神经疾病杂志,2011,14(4):95-96. 被引量:6
  • 7Hugh SM,Dirk WD,Manfred K,et al.Dual antiplatelet therapy withclopidogrel and aspilin in symptomatic carotid stenosis evaluated usingdoppler embolic signal detection:the clopidogrel and aspilin for reduc-tion of emboli in symptomatic carotid stenosis(CARESS)Trial[J].Circulation,2005,111:2233-2240.
  • 8Ka Sing,Lawrence Wong,Christopher Chen,et al.Clopidogrel plus as-pirin versus aspirin alone for reducing embolisation in patients with a-cute symptomatic cerebral or carotid artery stenosis(CLAIR study):arandomised,open-label,blinded-endpoint trial[J].Lancet Neural,2010,9:489-497.
  • 9Serebruany VL,Malinin AI,Oshrine BR,et al.Lack of uniform plate-let activation in patients after ischemic stroke and choice of antiplate-let therapy[J].Throm Res,2004,113(3~4):197-204.

二级参考文献21

  • 1孟江涛,高玉林.进展性缺血性卒中的研究近况[J].中国民康医学,2006,18(9):391-392. 被引量:2
  • 2GUO Yi,ZUO Yan-fang,WANG Qi-zhang,TANG Bing-shan,LI Fu-kang,SUN Yi.Meta-analysis of defibrase in treatment of acute cerebral infarction[J].Chinese Medical Journal,2006(8):662-668. 被引量:35
  • 3Karepov VG,Gur AY,Bova I,et al.Stroke-in-evolution:Infarct-inherent mechanisms versus systemic causes[J].Cerebrovasc Dis,2006,21(1/2):42-46.
  • 4Birschel P,Ellul J,Barer D.On behalf of the European progressing stroke study (EPSS) group:progressing stroke:Towards an internationaly agreed definition[J].Cerebrovase Dis,2004,17 (2/3):242-252.
  • 5Tei H,Uchiyama S,Ohara K,et al.Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project[J].Stroke,2000,31:2 049-2 054.
  • 6Kwan J,Hand P.Early neurological deterioration in acute stroke:clinical characteristics and impact on outcome[J].QJM,2006,99:625-633.
  • 7Caplan LR.Worsening in ischemic stroke patients:is it time for a new strategy?[J].Stroke,2002,33:1 443-1 445.
  • 8Pulsinelli W.Pathophysiology of acute ischaemic stroke[J].Lancet,1992,339:533-536.
  • 9Toni D,De Michele M,Fiorelli M,et al.Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion[J].J Neurol Sci,1994,123:129-133.
  • 10Ali LK,Saver JL.The ischemic stroke patient who worsens:new assessment and management approaches[J].Rev Neurol Dis,2007,4:85-91.

共引文献28

同被引文献161

引证文献15

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部